Literature DB >> 25846736

Clinical significance and biological roles of TRIM24 in human bladder carcinoma.

Dongwei Xue1, Xiuwei Zhang2, Xilin Zhang1, Jia Liu1, Ning Li1, Chunlai Liu1, Yili Liu1, Ping Wang3.   

Abstract

Tripartite motif-containing 24 (TRIM24), also known as transcription intermediary factor 1-alpha (TIF1α), is a chromatin-associated protein which as been has been implicated in carcinogenesis. However, its expression profile and biological roles in human bladder carcinoma has not been investigated. In this study, we examined its expression in 95 bladder cancer specimens. We found that TRIM24 expression was upregulated in 39 of 95 (41.1 %) specimens compared with normal control. TRIM24 overexpression was associated with local invasion and advanced grade of bladder cancer. In addition, we transfected TRIM24 plasmid into BIU-87 cell line and TRIM24 siRNA into 5637 cell line. Colony formation, CCK-8, and transwell assay were used to assess its biological roles in bladder cancer cells. The result showed that TRIM24 could facilitate cancer cell growth and invading ability. Western blot analysis demonstrated that TRIM24 upregulated cyclin D1, cyclin E, p-IκBα, and p-AKT expression, suggesting TRIM24 activates NF-κB and AKT pathways. In addition, NF-κB inhibitor reversed the effect of TRIM24 on cyclin D1. In conclusion, TRIM24 is overexpressed in human bladder cancer and facilitates bladder cancer growth and invasion, possibly through NF-κB and AKT signaling pathways.

Entities:  

Keywords:  AKT; Bladder cancer; NF-κB; Proliferation; TRIM24

Mesh:

Substances:

Year:  2015        PMID: 25846736     DOI: 10.1007/s13277-015-3393-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  21 in total

Review 1.  Exploiting the PI3K/AKT pathway for cancer drug discovery.

Authors:  Bryan T Hennessy; Debra L Smith; Prahlad T Ram; Yiling Lu; Gordon B Mills
Journal:  Nat Rev Drug Discov       Date:  2005-12       Impact factor: 84.694

Review 2.  TIF1 alpha: a chromatin-specific mediator for the ligand-dependent activation function AF-2 of nuclear receptors?

Authors:  B Le Douarin; A L Nielsen; J You; P Chambon; R Losson
Journal:  Biochem Soc Trans       Date:  1997-05       Impact factor: 5.407

3.  Clinical significance and biological roles of CARMA3 in human bladder carcinoma.

Authors:  Xiaojun Man; Jiani He; Chuize Kong; Yuyan Zhu; Zhe Zhang
Journal:  Tumour Biol       Date:  2014-01-18

4.  Clinical significance of UNC5B expression in bladder cancer.

Authors:  Jiao Liu; Zhe Zhang; Zhen-hua Li; Chui-Ze Kong
Journal:  Tumour Biol       Date:  2012-10-02

5.  Prognostic significance of TRIM24/TIF-1α gene expression in breast cancer.

Authors:  Monique Chambon; Béatrice Orsetti; Marie-Laurence Berthe; Caroline Bascoul-Mollevi; Carmen Rodriguez; Vanessa Duong; Michel Gleizes; Sandrine Thénot; Frédéric Bibeau; Charles Theillet; Vincent Cavaillès
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

Review 6.  Regulation of cyclin D1 gene expression.

Authors:  Ini-Isabée Witzel; Li Fang Koh; Neil D Perkins
Journal:  Biochem Soc Trans       Date:  2010-02       Impact factor: 5.407

7.  Ataxia-telangiectasia group D complementing gene (ATDC) upregulates matrix metalloproteinase 9 (MMP-9) to promote lung cancer cell invasion by activating ERK and JNK pathways.

Authors:  Zhong-Ping Tang; Quan-Zhe Cui; Qian-Ze Dong; Ke Xu; En-Hua Wang
Journal:  Tumour Biol       Date:  2013-05-17

8.  Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha.

Authors:  Konstantin Khetchoumian; Marius Teletin; Johan Tisserand; Manuel Mark; Benjamin Herquel; Mihaela Ignat; Jessica Zucman-Rossi; Florence Cammas; Thierry Lerouge; Christelle Thibault; Daniel Metzger; Pierre Chambon; Régine Losson
Journal:  Nat Genet       Date:  2007-11-18       Impact factor: 38.330

9.  Tumor suppressor TSLC1 is implicated in cell proliferation, invasion and apoptosis in laryngeal squamous cell carcinoma by regulating Akt signaling pathway.

Authors:  Baocai Lu; Wenyu Di; Huimin Wang; Huimin Ma; Jinsong Li; Qunmei Zhang
Journal:  Tumour Biol       Date:  2012-07-18

10.  Overexpression of TRIM24 is associated with the onset and progress of human hepatocellular carcinoma.

Authors:  Xiao Liu; Yu Huang; Dinghua Yang; Xianghong Li; Jiankun Liang; Liang Lin; Meng Zhang; Kebo Zhong; Bo Liang; Jialu Li
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

View more
  13 in total

1.  Histone H3 lysine 23 acetylation is associated with oncogene TRIM24 expression and a poor prognosis in breast cancer.

Authors:  Li Ma; Lili Yuan; Jing An; Michelle C Barton; Qingyuan Zhang; Zhaoliang Liu
Journal:  Tumour Biol       Date:  2016-09-16

2.  Overexpression of TRIM24 is correlated with the progression of human cervical cancer.

Authors:  Li Lin; Weihua Zhao; Bo Sun; Xinyu Wang; Qiao Liu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

3.  T-cell-intrinsic Tif1α/Trim24 regulates IL-1R expression on TH2 cells and TH2 cell-mediated airway allergy.

Authors:  Jimena Perez-Lloret; Isobel S Okoye; Riccardo Guidi; Yashaswini Kannan; Stephanie M Coomes; Stephanie Czieso; Gabrielle Mengus; Irwin Davidson; Mark S Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

4.  TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer.

Authors:  Anna C Groner; Laura Cato; Jonas de Tribolet-Hardy; Tiziano Bernasocchi; Hana Janouskova; Diana Melchers; René Houtman; Andrew C B Cato; Patrick Tschopp; Lei Gu; Andrea Corsinotti; Qing Zhong; Christian Fankhauser; Christine Fritz; Cédric Poyet; Ulrich Wagner; Tiannan Guo; Ruedi Aebersold; Levi A Garraway; Peter J Wild; Jean-Philippe Theurillat; Myles Brown
Journal:  Cancer Cell       Date:  2016-05-26       Impact factor: 31.743

5.  TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels.

Authors:  Ankush Borlepawar; Ashraf Yusuf Rangrez; Alexander Bernt; Lynn Christen; Samuel Sossalla; Derk Frank; Norbert Frey
Journal:  J Biol Chem       Date:  2017-05-02       Impact factor: 5.157

6.  TRIM24 promotes the aggression of gastric cancer via the Wnt/β-catenin signaling pathway.

Authors:  Ziling Fang; Jun Deng; Ling Zhang; Xiaojun Xiang; Feng Yu; Jun Chen; Miao Feng; Jianping Xiong
Journal:  Oncol Lett       Date:  2017-01-17       Impact factor: 2.967

Review 7.  TRIM family contribute to tumorigenesis, cancer development, and drug resistance.

Authors:  Ning Huang; Xiaolin Sun; Peng Li; Xin Liu; Xuemei Zhang; Qian Chen; Hong Xin
Journal:  Exp Hematol Oncol       Date:  2022-10-19

8.  Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer.

Authors:  Ziling Fang; Ling Zhang; Quan Liao; Yi Wang; Feng Yu; Miao Feng; Xiaojun Xiang; Jianping Xiong
Journal:  J Exp Clin Cancer Res       Date:  2017-01-23

9.  TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma.

Authors:  Deguan Lv; Yanxin Li; Weiwei Zhang; Angel A Alvarez; Lina Song; Jianming Tang; Wei-Qiang Gao; Bo Hu; Shi-Yuan Cheng; Haizhong Feng
Journal:  Nat Commun       Date:  2017-11-13       Impact factor: 14.919

10.  Identification of key genes and pathways downstream of the β-catenin-TCF7L1 complex in pancreatic cancer cells using bioinformatics analysis.

Authors:  Yi-Hang Yuan; Jian Zhou; Yan Zhang; Meng-Dan Xu; Jing Wu; Wei Li; Meng-Yao Wu; Dao-Ming Li
Journal:  Oncol Lett       Date:  2019-06-06       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.